companydata.dkResistance Oncology ApS: Financial statements 2022
CVR: 36945125
Resistance Oncology ApS (CVR 36945125) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -11,970 and a net result of DKK -10,252 compared with DKK -8,615 the year before. Equity amounted to DKK -41,431.
- Gross Profit
- -11,970 kr.
- Profit/Loss
- -10,252 kr.
- Equity
- -41,431 kr.
- Total Assets
- 6,821 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -12 t. | -10 t. | -41 t. | - |
| 2021 | - | -10 t. | -9 t. | -31 t. | - |
| 2020 | - | -10 t. | -8 t. | -23 t. | - |
| 2019 | - | 14 t. | 10 t. | -15 t. | - |
| 2018 | - | -15 t. | -13 t. | -25 t. | - |
Keep an eye on Resistance Oncology ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 1, 2022, Nils Aage Brünner is registered as director of Resistance Oncology ApS.
Resistance Oncology ApS has published its annual report for 2021. Gross profit came to DKK -10,140, and the net result was DKK -8,615.
As of July 6, 2022, Kasper Pasternak Jørgensen is registered as director of Resistance Oncology ApS.
As of July 6, 2022, Jørgen Peter Jørgensen has stepped down as director of Resistance Oncology ApS.
About Resistance Oncology ApS
Resistance Oncology ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named 3B-Oncology ApS and Cortris Nordic ApS. The management consists of Nils Aage Brünner and Kasper Pasternak Jørgensen. The company is owned by TIMPCO NB ApS, Alexander Meier Holding ApS and Pasternak Holding ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK -410,610 and a net result of DKK -665,070 compared with DKK -29,048 the year before. Equity amounted to DKK 325,631.